The concordance study of MSI status between Guardant360 and MSI test kit (FALCO) (GOZILA additional study 01)
Not Applicable
- Conditions
- Patients with unresectable advanced / recurrent gastrointestinal / abdominal malignancies
- Registration Number
- JPRN-UMIN000042612
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
ctDNA genotyping was able to detect MSI with high concordance to validated tissue-based MSI testing, especially in patients with tumors that have sufficient ctDNA shedding.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2385
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are inappropriate to participate in this study for any reasons
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method